CervoMed Inc. (CRVO) shares rallied 11.6% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 13.3% gain over the past four weeks.The sudden price rise can be attributed to growing investor optimism related to the company’s progress in studies on its pipeline candidate, neflamapimod, which is being developed for treating Dementia with Lewy Bodies and other major neur ...